Company profile for Shoreline Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Shoreline Biosciences is developing clinically effective allogeneic, off-the-shelf, targeted, and standardized immunotherapies using intelligently engineered induced Pluripotent Stem Cell (iPSC)-derived NK cells and macrophages for serious diseases. Shoreline’s proprietary cell therapy platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced persistenc...
Shoreline Biosciences is developing clinically effective allogeneic, off-the-shelf, targeted, and standardized immunotherapies using intelligently engineered induced Pluripotent Stem Cell (iPSC)-derived NK cells and macrophages for serious diseases. Shoreline’s proprietary cell therapy platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced persistence and tumor killing. In addition, the company aims to restore tissue homeostasis and function by introducing engineered macrophages for fibrotic and inflammatory pathologies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11408 Sorrento Valley Road San Diego, CA 92121
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/gileads-kite-pharma-erodes-23b-shelf-cell-therapy-deal-shoreline-biosciences

FIERCE BIOTECH
03 Sep 2025

https://endpts.com/beigene-ends-pact-with-shoreline-its-entry-into-cell-therapy/

Kyle LaHucik ENDPTS
26 Feb 2024

https://www.prnewswire.com/news-releases/shoreline-biosciences-to-participate-at-the-2023-wedbush-pacgrow-healthcare-conference-301892697.html

PR NEWSWIRE
03 Aug 2023

https://www.contractpharma.com/contents/view_breaking-news/2023-02-21/shoreline-biosciences-names-mauro-avanzi-chief-med/?widget=listSection

CONTRACT PHARMA
21 Feb 2023

https://www.biopharmadive.com/news/editas-shoreline-sell-deal-nk-cell-therapy/640748/

BIOPHARMADIVE
20 Jan 2023

https://www.prnewswire.com/news-releases/shoreline-biosciences-to-present-two-posters-on-ink-cell-platform-at-19th-meeting-of-the-society-for-natural-immunity-nk2022-301544193.html

PRNEWSWIRE
10 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty